[Improvement of sensoneurinal hearing loss in a patient with Muckle-Wells syndrome treated with anakinra].
Muckle Wells syndrome is an autoinflammatory disease in the group of cryopyrin associated periodic syndromes (CAPS). We report the case of an 8 year old girl with MWS who presented with remitting fever, urticaria, remitting coxitis, osteitis, bilateral uveitis anterior, elevated levels of C-reactive protein (CRP) and Serum amyloid A (SAA) and progressive sensoneurinal hearing loss. After starting treatment with anakinra, clinical symptoms dissolved almost completely for about two years now. CRP and SAA levels normalized quickly and sustained and as a consequence the risk of amyloidosis may be minimized. Notable is the complete recovery from sensoneurinal hearing loss merely two months after start of treatment. This brings up questions about pathophysiology of sensoneurinal hearing loss in MWS and emphasizes the benefits of an early diagnosis, as an early start of treatment possibly reduces long-term damage.
Klein
A K
AK
Asklepios Kinderklinik Sankt Augustin, Zentrum für Allgemeine Pädiatrie und Neonatologie, Arnold-Janssen-Strasse 29, Sankt Augustin, Germany. ar.klein@asklepios.com
Horneff
G
G
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001301:Audiometry, Pure-Tone; D001309:Auditory Threshold / Q000187:drug effects*; D002648:Child; D056587:Cryopyrin-Associated Periodic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D004252:DNA Mutational Analysis; D005260:Female; D006580:Genetic Carrier Screening; D006316:Hearing Loss, High-Frequency / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008134:Long-Term Care
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein